K Pharm Corporation was established in 2021 with a vision to propose a new direction for the future of K-Beauty in the global medical aesthetics industry.
Following the COVID-19 pandemic, the Korean aesthetic market faced a period of stagnation. In response, K Pharm was founded to introduce innovative and practical alternatives within the medical aesthetic field by connecting proven Korean technologies with the growing demands of global markets.

Our company covers both medical aesthetic devices and aesthetic treatment products, offering carefully selected solutions that have already been verified in Korea’s highly demanding medical device market.
By identifying high-quality yet globally underrecognized products, K Pharm Corporation has successfully introduced Korean innovations to international markets. One example is Triple Body, a clinically validated body-contouring device in Korea that has achieved a successful launch across Asian markets through our global distribution network.

We have also worked closely with manufacturers to introduce emerging Korean aesthetic technologies to global markets. LHALA Peel is a representative example. Once a relatively unknown product, it has now grown into a globally recognized brand across Asia, the Middle East, Europe, and the Americas.

Through these efforts, K Pharm Corporation continues to bridge Korean medical aesthetic innovation with global demand, providing reliable products and strategic market expansion.